Adam M. Koppel

Adam M. Koppel

DirectoratSolid Biosciences· In proxies 2023–2024

Adam M. Koppel sits on 4 public boards.

Experience

  1. Solid BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +23%
  2. Foghorn TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Areteia Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Cardurion Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Cerevel Therapeutics Holdings, IncPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?